<sup>68</sup>Ga-Labeled Gold Glyconanoparticles for
Exploring Blood–Brain Barrier Permeability: Preparation, Biodistribution
Studies, and Improved Brain Uptake via Neuropeptide Conjugation
- Publication date
- Publisher
Abstract
New tools and techniques to improve
brain visualization and assess
drug permeability across the blood–brain barrier (BBB) are
critically needed. Positron emission tomography (PET) is a highly
sensitive, noninvasive technique that allows the evaluation of the
BBB permeability under normal and disease-state conditions. In this
work, we have developed the synthesis of novel water-soluble and biocompatible
glucose-coated gold nanoparticles (GNPs) carrying BBB-permeable neuropeptides
and a chelator of the positron emitter <sup>68</sup>Ga as a PET reporter
for in vivo tracking biodistribution. The small GNPs (2 nm) are stabilized
and solubilized by a glucose conjugate. A NOTA ligand is the chelating
agent for the <sup>68</sup>Ga, and two related opioid peptides are
used as targeting ligands for improving BBB crossing. The radioactive
labeling of the GNPs is completed in 30 min at 70 °C followed
by purification via centrifugal filtration. As a proof of principle,
a biodistribution study in rats is performed for the different <sup>68</sup>Ga-GNPs. The accumulation of radioactivity in different organs
after intravenous administration is measured by whole body PET imaging
and gamma counter measurements of selected organs. The biodistribution
of the <sup>68</sup>Ga-GNPs varies depending on the ligands, as GNPs
with the same gold core size show different distribution profiles.
One of the targeted <sup>68</sup>Ga-GNPs improves BBB crossing near
3-fold (0.020 ± 0.0050% ID/g) compared to nontargeted GNPs (0.0073
± 0.0024% ID/g) as measured by dissection and tissue counting